These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 24853998)

  • 61. Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 as predictors of all-cause and cardiovascular mortality in patients with Type 1 diabetes with and without diabetic nephropathy.
    Theilade S; Lajer M; Jorsal A; Tarnow L; Parving HH; Rossing P
    Diabet Med; 2012 Mar; 29(3):337-44. PubMed ID: 21988672
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Monocyte to HDL ratio: a novel marker of resistant hypertension in CKD patients.
    Gembillo G; Siligato R; Cernaro V; Satta E; Conti G; Salvo A; Romeo A; Calabrese V; Sposito G; Ferlazzo G; Santoro D
    Int Urol Nephrol; 2022 Feb; 54(2):395-403. PubMed ID: 34109496
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks.
    Li XM; Tang WH; Mosior MK; Huang Y; Wu Y; Matter W; Gao V; Schmitt D; Didonato JA; Fisher EA; Smith JD; Hazen SL
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1696-705. PubMed ID: 23520163
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cystatin C identifies patients with stable chronic heart failure at increased risk for adverse cardiovascular events.
    Dupont M; Wu Y; Hazen SL; Tang WH
    Circ Heart Fail; 2012 Sep; 5(5):602-9. PubMed ID: 22899766
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Association Between Serum High-Density Lipoprotein Cholesterol Levels and Progression of Chronic Kidney Disease: Results From the KNOW-CKD.
    Nam KH; Chang TI; Joo YS; Kim J; Lee S; Lee C; Yun HR; Park JT; Yoo TH; Sung SA; Lee KB; Oh KH; Kim SW; Lee J; Kang SW; Choi KH; Ahn C; Han SH;
    J Am Heart Assoc; 2019 Mar; 8(6):e011162. PubMed ID: 30859896
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Relation between Kidney Length and Cardiovascular and Renal Risk in High-Risk Patients.
    van der Sande NGC; Visseren FLJ; van der Graaf Y; Nathoe HM; de Borst GJ; Leiner T; Blankestijn PJ;
    Clin J Am Soc Nephrol; 2017 Jun; 12(6):921-928. PubMed ID: 28487344
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD.
    Bajaj A; Xie D; Cedillo-Couvert E; Charleston J; Chen J; Deo R; Feldman HI; Go AS; He J; Horwitz E; Kallem R; Rahman M; Weir MR; Anderson AH; Rader DJ;
    Am J Kidney Dis; 2019 Jun; 73(6):827-836. PubMed ID: 30686529
    [TBL] [Abstract][Full Text] [Related]  

  • 68. LDL-C/apoB and HDL-C/apoA-1 ratios predict incident chronic kidney disease in a large apparently healthy cohort.
    Bae JC; Han JM; Kwon S; Jee JH; Yu TY; Lee MK; Kim JH
    Atherosclerosis; 2016 Aug; 251():170-176. PubMed ID: 27341533
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prognostic effect of high-density lipoprotein cholesterol level in patients with atherosclerotic cardiovascular disease under statin treatment.
    Li YH; Tseng WK; Yin WH; Lin FJ; Wu YW; Hsieh IC; Lin TH; Sheu WH; Yeh HI; Chen JW; Wu CC;
    Sci Rep; 2020 Dec; 10(1):21835. PubMed ID: 33318590
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases.
    Ganjali S; Gotto AM; Ruscica M; Atkin SL; Butler AE; Banach M; Sahebkar A
    J Cell Physiol; 2018 Dec; 233(12):9237-9246. PubMed ID: 30076716
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years.
    Krumholz HM; Seeman TE; Merrill SS; Mendes de Leon CF; Vaccarino V; Silverman DI; Tsukahara R; Ostfeld AM; Berkman LF
    JAMA; 1994 Nov; 272(17):1335-40. PubMed ID: 7772105
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Intact fibroblast growth factor 23 levels predict incident cardiovascular event before but not after the start of dialysis.
    Nakano C; Hamano T; Fujii N; Obi Y; Matsui I; Tomida K; Mikami S; Inoue K; Shimomura A; Nagasawa Y; Okada N; Tsubakihara Y; Rakugi H; Isaka Y
    Bone; 2012 Jun; 50(6):1266-74. PubMed ID: 22425694
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Blood lipids and lipoproteins in relation to incidence and mortality risks for CVD and cancer in the prospective EPIC-Heidelberg cohort.
    Katzke VA; Sookthai D; Johnson T; Kühn T; Kaaks R
    BMC Med; 2017 Dec; 15(1):218. PubMed ID: 29254484
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Triglyceride to high-density lipoprotein cholesterol ratio predicts cardiovascular outcomes in prevalent dialysis patients.
    Chen HY; Tsai WC; Chiu YL; Hsu SP; Pai MF; Yang JY; Peng YS
    Medicine (Baltimore); 2015 Mar; 94(10):e619. PubMed ID: 25761189
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Safety and efficacy of atorvastatin in patients with severe renal dysfunction.
    Holmberg B; Brännström M; Bucht B; Crougneau V; Dimeny E; Ekspong A; Granroth B; Gröntoft KC; Hadimeri H; Ingman B; Isaksson B; Johansson G; Lindberger K; Lundberg L; Mikaelsson L; Olausson E; Persson B; Welin D; Wikdahl AM; Stegmayr BG
    Scand J Urol Nephrol; 2005; 39(6):503-10. PubMed ID: 16303728
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Endostatin in chronic kidney disease: Associations with inflammation, vascular abnormalities, cardiovascular events and survival.
    Kanbay M; Afsar B; Siriopol D; Unal HU; Karaman M; Saglam M; Gezer M; Taş A; Eyileten T; Guler AK; Aydin İ; Oguz Y; Tarim K; Covic A; Yilmaz MI
    Eur J Intern Med; 2016 Sep; 33():81-7. PubMed ID: 27394925
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Serum C-reactive protein levels in pre-dialysis chronic kidney disease patientsin southern Nigeria.
    Adejumo OA; Okaka EI; Okwuonu CG; Iyawe IO; Odujoko OO
    Ghana Med J; 2016 Mar; 50(1):31-8. PubMed ID: 27605722
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Monocyte to high-density lipoprotein ratio and cardiovascular events in patients on peritoneal dialysis.
    Zhan X; Pan D; Wei X; Wen D; Yan C; Xiao J
    Nutr Metab Cardiovasc Dis; 2020 Jun; 30(7):1130-1136. PubMed ID: 32446868
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Plasma homocysteine levels and cardiovascular mortality in patients with end-stage renal disease.
    Buccianti G; Baragetti I; Bamonti F; Furiani S; Dorighet V; Patrosso C
    J Nephrol; 2004; 17(3):405-10. PubMed ID: 15365961
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study.
    Tokmakova MP; Skali H; Kenchaiah S; Braunwald E; Rouleau JL; Packer M; Chertow GM; Moyé LA; Pfeffer MA; Solomon SD
    Circulation; 2004 Dec; 110(24):3667-73. PubMed ID: 15569840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.